Our focus on GLP-1 for metabolic health Chicago and personalized care makes it an ideal option for addressing metabolic risk factors, including high blood pressure and abnormal cholesterol
Since then, the class has quickly grown to include albiglutide, dulaglutide, liraglutide, lixisenatide, and semaglutide
Am J Physiol Endocrinol Metab 292(2):E543-548
Mounjaro is significantly more effective for weight loss, achieving approximately 21% body weight reduction versus 8% with Rybelsus (roughly 2.5x greater)
Others report a diminished sense of enjoyment from eating
While injectable GLP-1-based therapy uptake has been well documented ( 8 ), far less is known about how quickly newly approved obesity therapies are adopted in routine clinical practice, particularly in the weeks immediately following approval